Previous 10 | Next 10 |
Delcath Systems to Host Third Quarter 2022 Results PR Newswire NEW YORK , Oct. 24, 2022 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, annou...
Delcath Systems to Participate at the H.C. Wainwright 24th Annual Global Investor Conference on September 12 and 13, 2022 PR Newswire NEW YORK , Sept. 1, 2022 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused...
Delcath Systems, Inc. (DCTH) Q2 2022 Earnings Conference Call August 8, 2022 8:30 AM ET Company Participants David Hoffman - General Counsel Gerard Michel - Chief Executive Officer Anthony Dias - Vice President of Finance Johnny John - Senior Vice President o...
Delcath Systems press release ( NASDAQ: DCTH ): Q2 GAAP EPS of -$1.18 misses by $0.23 . Revenue of $0.8M (+48.1% Y/Y) beats by $0.38M . On June 30, 2022, the company had cash, cash equivalents and restricted cash totaling $14.4M, as compared to cash, cash equiv...
Delcath Systems Reports Second Quarter 2022 Results and Provides Business Update PR Newswire NEW YORK , Aug. 8, 2022 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastati...
Delcath Systems ( NASDAQ: DCTH ) is scheduled to announce Q2 earnings results on Monday, August 8th, before market open. The consensus EPS Estimate is -$1.01 (-5.2% Y/Y) and the consensus Revenue Estimate is $0.42M (-22.2% Y/Y). Over the last 3 months, EPS estimates ha...
ANIP , APRN , ASRT , BNTX , CLVS , D , DCTH , DTIL , ELAN , ENR , FREY , GOLD , HE , HEP , ITUB , KNDI , KOS , LINC , OTCPK:LKNCY , OSG , PDSB , PLTR , PRTY , RDWR , RETA , SOHU , TGN...
Results of a Multicenter Study on Delcath's CHEMOSAT® Hepatic Delivery System Published in Cardiovascular and Interventional Radiology PR Newswire Retrospective study in metastatic uveal melanoma patients with liver dominant disease shows an objective response r...
Delcath Systems to Host Second Quarter 2022 Results PR Newswire NEW YORK , July 27, 2022 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, anno...
Delcath Systems Closes Private Placement of $5.0 Million PR Newswire NEW YORK , July 20, 2022 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver,...
News, Short Squeeze, Breakout and More Instantly...
Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced today it will host a conference call on August 5, 2024, at 4:30 PM Eastern Time to discuss results for its second quarter ended June 30, 2024...
2024-07-16 23:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-17 07:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...